Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs 22nd Century Group Inc (XXII) Price & Performance

CVS Health CorpTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs 22nd Century Group Inc — how do they compare? CVS Health Corp trades at $93.5 (market cap $119.58B), while 22nd Century Group Inc trades at $4.46 (market cap $1.52M). The key difference: CVS Health Corp is far larger — about 78671.1× 22nd Century Group Inc's market cap, and CVS Health Corp pays a 2.84% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.

CVSXXII
Market Cap
$119.58B$1.52M
Sector
HealthTechnology
52-Week High
$110.60$801.00
52-Week Low
$65.51$3.72
Enterprise Value
$181.93B-$6.71M
Dividend Yield
2.84%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.

The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.

22nd Century Group Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII